
Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, is carving out a niche with its innovative drug discovery and development software solutions. With a market capitalization of..
LifeMD, Inc. (NASDAQ: LFMD) is stirring interest in the healthcare sector with its innovative approach to telehealth services. With a market capitalization of $275.02 million, LifeMD stands out in the..
Myriad Genetics, Inc. (NASDAQ: MYGN) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. As a molecular diagnostic testing and precision medicine company, Myriad..
Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors with its staggering potential upside of 2,611.07%, a figure that stands out in the high-stakes world of biotechnology. As a..
OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, particularly within the medical devices industry, as a unique player focused on pediatric orthopedic solutions. Headquartered in Warsaw, Indiana, the..
Bioventus Inc. (NASDAQ: BVS), a key player in the medical devices sector, stands as a noteworthy investment candidate for those eyeing substantial growth potential within the healthcare industry. With its..
For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands as a compelling opportunity, especially with a notable potential upside of 69.88% based on the..
Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $372.73 million, this Santa Clara-based company is..
Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly in diagnostics and research, with its cutting-edge cancer genomic tests and services. Even as the company grapples with..
For investors looking to tap into the healthcare sector’s promise, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity. This specialty pharmaceutical company is making significant strides in the development..
Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is captivating investor attention with its innovative approach to gene and cell therapy. Headquartered in Germantown, Maryland, this biopharmaceutical..
Investors looking for opportunities in the health information services sector may want to consider Weave Communications, Inc. (NYSE: WEAV). With a market capitalization of $503.05 million, Weave is carving out..
MeiraGTx Holdings plc (NASDAQ: MGTX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious approach to genetic medicine. Specializing in innovative therapies for..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising portfolio of therapies targeting autoimmune diseases and cancer. Based in Cambridge,..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company based in South San Francisco, California, is garnering attention for its innovative approach in addressing critical healthcare challenges. Operating within the healthcare..
Arvinas, Inc. (NASDAQ: ARVN) is a name that has been generating interest among investors, particularly in the healthcare sector, where innovation often leads to significant stock value appreciation. With a..
Investors eyeing the biotechnology sector may find Trevi Therapeutics, Inc. (NASDAQ: TRVI) a compelling prospect, particularly given the remarkable potential upside of 84.42% as identified by analysts. This clinical-stage biopharmaceutical..
Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology sector, with its robust focus on providing innovative solutions for biopharmaceutical product and medical device development. As a contract..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a U.S.-based biotechnology firm, has been generating buzz in the healthcare sector with its innovative approach to gene therapies targeting monogenic diseases of the..
Valneva SE (NASDAQ: VALN), a French biotech company, is making headlines in the healthcare sector with its strong revenue growth and promising pipeline of vaccines for infectious diseases. With a..